Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study will determine if aspirin from PL2200, an investigational product, gets into the
blood stream as quickly as enteric coated aspirin, and to test whether PL2200 is able to
prevent blood clots as effectively as enteric coated aspirin, when administered to patients
with diabetes